1-3 of 3
John M. Maris
Close
Sort by
Journal Articles

DNMT3A overgrowth syndrome is associated with the development of hematopoietic malignancies in children and young adults

Clinical Trials & Observations
Margaret A. Ferris, Amanda M. Smith, Sharon E. Heath, Eric J. Duncavage, Matthew Oberley, David Freyer, Robert Wynn, Sofia Douzgou, John M. Maris, Anne F. Reilly, Melinda D. Wu, Florence Choo, Roel B. Fiets, Saskia Koene, David H. Spencer, Christopher A. Miller, Marwan Shinawi, Timothy J. Ley
Journal: Blood
Blood (2022) 139 (3): 461–464.
https://doi.org/10.1182/blood.2021014052
Published: 2022
Includes: Supplemental data
Journal Articles

Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS)

David T. Teachey, Dana A. Obzut, Kelly Axsom, John K. Choi, Kelly C. Goldsmith, Junior Hall, Jessica Hulitt, Catherine S. Manno, John M. Maris, Nicholas Rhodin, Kathleen E. Sullivan, Valerie I. Brown, Stephan A. Grupp
Journal: Blood
Blood (2006) 108 (6): 1965–1971.
https://doi.org/10.1182/blood-2006-01-010124
Published: 2006
Includes: Supplemental data
Journal Articles

Evidence for Genetic Homogeneity in a Familial Platelet Disorder With Predisposition to Acute Myelogenous Leukemia (FPD/AML)

Gowthami Arepally, Timothy R. Rebbeck, Woojoo Song, Gary Gilliland, John M. Maris, Mortimer Poncz
Journal: Blood
Blood (1998) 92 (7): 2600–2602.
https://doi.org/10.1182/blood.V92.7.2600
Published: 1998